The Regulation of Proprotein Convertase Subtilisin/ Kexin Type 9 and Its Liver Involvement

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 21, Issue 11

Abstract

Introduction: Anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies have been very effective to lower low-density lipoprotein (LDL)-cholesterol. They attracted the attention on PCSK9 enzyme role in multiple pathways and underlined the complex correlations between lipid metabolism and various other liver or extrahepatic diseases, that are insufficiently known. Hepatocyte nuclear factor 1, sterol regulatory element-binding protein (SREBP) 1c and SREBP2 are the main modulators of liver PCSK9 gene and protein expression, processes that can also be influenced by some natural and synthetic compounds (as berberine, or bortezomib and rosuvastatin, respectively), endoplasmic reticulum stress, metabolic status and the diurnal pattern. Aim: This minireview is an analysis of PCSK9 involvement in liver pathology. Results and Conclusion: PCSK9 is a key enzyme which increases LDL-receptor degradation. Hepatitis C virus (HCV) enters into hepatocytes in combination with lipoproteins through LDL-receptors and negatively modulates the PCSK9 expression to reduce LDL-receptor degradation and increase HCV entry into hepatocyte. PCSK9 modulates the hepatic CD81 - a mediator of post-attachment process. The greater the liver lipid accumulation the higher the plasma levels of PCSK9, which were observed in non-alcoholic fatty liver disease. A decreased expression of PCSK9 and an increased expression of LDL-receptor were shown in liver samples from patients with hepatocellular carcinoma, a fact that suggests that these cancer cells are able to modulate their local microenvironment to obtain a higher amount of cellular cholesterol. With better understanding of the role of this enzyme, PCSK9 and the factors involved in its regulation can become targets for the treatment of different liver pathologies.

Authors and Affiliations

R. G. Mihăilă

Keywords

Related Articles

Potential Relationship between Self-Assessed Eating Speed and Recalled Duration of Eating Meals in Apparently Healthy Adults

Background: Self-assessed eating speed was frequently used to assess an individual’s eating speed in previous clinical studies. However, the relationship between self-assessed eating speed and the duration of eating meal...

The Effects of a Delay Following Warm-up on the Heart Rate Response to Sudden Strenuous Exercise

Introduction: Sudden strenuous exercise (SSE) has previously been shown to result in electrocardiograph (ECG) abnormalities indicative of myocardial ischemia when not preceded by a warm-up. Athletes regularly undergo SSE...

Incidence of Sigmoid Volvulus in Northern Uganda: A Cross-Sectional Study Design

Aims: To determine the incidence of sigmoid volvulus in Northern Uganda. Study Design: A cross-sectional (2 years retrospective and one year prospective) study design was conducted on patients’ medical records and those...

Experience with Parental Vaccination Refusal and Attitudes about Vaccinations of Pediatricians in Greece

Aim: To study the experience of Greek pediatricians with parents who refuse their children's vaccination and their attitudes towards vaccinations. Study Design: Nation-wide questionnaire-based survey conducted from Fe...

Infantile Fibrosarcoma- An Unusual Presentation

Soft tissue tumours account for ∼ 25% of all congenital tumours, among which infantile fibrosarcoma is one of the most common nonrhabdomyosarcoma. Infantile fibrosarcoma is a soft-tissue sarcoma occuring under 1 year of...

Download PDF file
  • EP ID EP311820
  • DOI 10.9734/BJMMR/2017/33548
  • Views 59
  • Downloads 0

How To Cite

R. G. Mihăilă (2017). The Regulation of Proprotein Convertase Subtilisin/ Kexin Type 9 and Its Liver Involvement. Journal of Advances in Medicine and Medical Research, 21(11), 1-12. https://europub.co.uk/articles/-A-311820